American Journal of Kidney Diseases
Volume 52, Issue 3 , Pages 519-530 , September 2008

Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

  • Francesca Tentori, MD

      Affiliations

    • Arbor Research Collaborative for Health, University of Michigan, Ann Arbor, MI
    • Corresponding Author InformationAddress correspondence to Francesca Tentori, MD, Arbor Research Collaborative for Health, 315 W Huron St, Ste 360, Ann Arbor, MI 48103
    • ,
  • Margaret J. Blayney, MS

      Affiliations

    • Arbor Research Collaborative for Health, University of Michigan, Ann Arbor, MI
    • ,
  • Justin M. Albert, BA

      Affiliations

    • Arbor Research Collaborative for Health, University of Michigan, Ann Arbor, MI
    • ,
  • Brenda W. Gillespie, PhD

      Affiliations

    • Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI
    • ,
  • Peter G. Kerr, MBBS, PhD, FRACP

      Affiliations

    • Monash Medical Centre/Monash University, Clayton, Victoria, Australia
    • ,
  • Jürgen Bommer, MD

      Affiliations

    • University of Heidelberg, Heidelberg, Germany
    • ,
  • Eric W. Young, MD, MS

      Affiliations

    • Veterans Affairs Medical Center/University of Michigan, Ann Arbor, MI
    • ,
  • Tadao Akizawa, MD

      Affiliations

    • Showa University, Tokyo, Japan
    • ,
  • Takashi Akiba, MD

      Affiliations

    • Tokyo Women's Medical University, Tokyo, Japan
    • ,
  • Ronald L. Pisoni, PhD

      Affiliations

    • Arbor Research Collaborative for Health, University of Michigan, Ann Arbor, MI
    • ,
  • Bruce M. Robinson, MD, MS

      Affiliations

    • Arbor Research Collaborative for Health, University of Michigan, Ann Arbor, MI
    • ,
  • Friedrich K. Port, MD, MS

      Affiliations

    • Arbor Research Collaborative for Health, University of Michigan, Ann Arbor, MI

Received 16 October 2007 ,Accepted 24 March 2008.

References 

  1. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–1483
  2. Qunibi WY, Nolan CA, Ayus JC. Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon. Kidney Int Suppl. 2002;82:S73–S80
  3. Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16:520–528
  4. London GM, Guerin AP, Verbeke FH, et al. Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007;18:613–620
  5. Krasniak A, Drozdz M, Pasowicz M, et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant. 2007;22:515–521
  6. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–2218
  7. Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int. 2006;70:351–357
  8. Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69:1945–1953
  9. Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol. 2004;15:770–779
  10. Noordzij M, Korevaar JC, Boeschoten EW, et al. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: Association with mortality in dialysis patients. Am J Kidney Dis. 2005;46:925–932
  11. Tentori F, Hunt WC, Rohrscheib M, et al. Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?. J Am Soc Nephrol. 2007;18:2377–2384
  12. Young EW, Akiba T, Albert JM, et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Am J Kidney Dis. 2004;44(suppl 2):S34–S38
  13. Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005;67:1179–1187
  14. Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70:771–780
  15. Tanaka M, Yamazaki S, Hayashino Y, et al. Hypercalcaemia is associated with poor mental health in haemodialysis patients: Results from Japan DOPPS. Nephrol Dial Transplant. 2007;22:1658–1664
  16. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15:458–482
  17. Foley RN, Parfrey PS, Harnett JD, et al. Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am J Nephrol. 1996;16:386–393
  18. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001;12:2131–2138
  19. Plantinga LC, Fink NE, Jaar BG, et al. Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: A prospective cohort study. BMC Health Serv Res. 2007;7:5
  20. Jadoul M, Albert JM, Akiba T, et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2006;70:1358–1366
  21. Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis. 2006;47:149–156
  22. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003;42(suppl 3):S1–S202
  23. Jindal K, Chan CT, Deziel C, et al. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol. 2006;17(suppl 1):S1–S27
  24. Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the Renal Association, and the Royal College of General Practitioners. Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral. London, UK: Royal College of Physicians; 2006;
  25. Elder G, Faull R, Branley P, Hawley C. Management of bone disease, calcium, phosphate and parathyroid hormone. Nephrology. 2006;11(suppl 1):S230–S261
  26. Cannata-Andía JB Medical Working Group. Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant. 2000;15(suppl 5):S43
  27. Vanbelleghem H, Vanholder R, Levin NW, et al. The Kidney Disease: Improving Global Outcomes website: Comparison of guidelines as a tool for harmonization. Kidney Int. 2007;71:1054–1061
  28. Young EW, Goodkin DA, Mapes DL, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study. Kidney Int Suppl. 2000;74:S74–S81
  29. Pisoni RL, Gillespie BW, Dickinson DM, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodology. Am J Kidney Dis. 2004;44:7–15
  30. Portale AA. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. In:  Favus MJ editors. Blood calcium, phosphorus, and magnesium. Philadelphia, PA: Lippincott, Williams & Wilkins; 1999;p. 115–118
  31. Klein J, Moeschberger M. Survival Analysis Techniques for Censored and Truncated Data. In: New York, NY: Springer; 1997;p. 416–418
  32. Port FK, Wolfe RA, Held PJ, Young EW. Random sample (DOPPS) versus census-based registry approaches to kidney disease research. Blood Purif. 2003;21:85–88
  33. Wald R, Tentori F, Tighiouart H, Zager PG, Miskulin DC. Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network. Am J Kidney Dis. 2007;49:257–266
  34. Faull RJ. Managing bone parameters in dialysis patients: International guideline conflicts. Semin Dial. 2007;20:191–194
  35. Clase CM, Norman GL, Beecroft ML, Churchill DN. Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrol Dial Transplant. 2000;15:1841–1846
  36. Johnston SC. Combining ecological and individual variables to reduce confounding by indication: Case study—Subarachnoid hemorrhage treatment. J Clin Epidemiol. 2000;53:1236–1241
  37. Sigrist MK, Devlin L, Taal MW, Fluck RJ, McIntyre CW. Length of interdialytic interval influences serum calcium and phosphorus concentrations. Nephrol Dial Transplant. 2005;20:1643–1646

 Originally published online as doi:10.1053/j.ajkd.2008.03.020 on June 2, 2008.

PII: S0272-6386(08)00653-7

doi: 10.1053/j.ajkd.2008.03.020

American Journal of Kidney Diseases
Volume 52, Issue 3 , Pages 519-530 , September 2008

Article Tools

* Image Usage & Resolution